User profiles for A. C. Gordon

Anthony Gordon

- Verified email at imperial.ac.uk - Cited by 36178

Andrew C Gordon, MD, PhD

- Verified email at northwestern.edu - Cited by 1141

Artificial intelligence versus clinicians: systematic review of design, reporting standards, and claims of deep learning studies

M Nagendran, Y Chen, CA Lovejoy, AC Gordon… - bmj, 2020 - bmj.com
Objective To systematically examine the design, reporting standards, risk of bias, and claims
of studies comparing the performance of diagnostic deep learning algorithms for medical …

[HTML][HTML] Redefining critical illness

…, EJ Giamarellos-Bourboulis, AC Gordon… - Nature medicine, 2022 - nature.com
Research and practice in critical care medicine have long been defined by syndromes,
which, despite being clinically recognizable entities, are, in fact, loose amalgams of …

[HTML][HTML] Levosimendan: current data, clinical use and future development

…, LMA Heunks, PK Suominen, AC Gordon… - Heart, lung and …, 2013 - ncbi.nlm.nih.gov
AC Gordon in conjunction with the Imperial Clinical Trials Unit) assessing the role of …
Fruhwald, AC Gordon and LMA Heunk. received limited grants and honoraria from Orion …

Association between administration of systemic corticosteroids and mortality among critically ill patients with COVID-19: a meta-analysis

…, B Du, J Emberson, D Fisher, B Giraudeau, AC Gordon… - Jama, 2020 - jamanetwork.com
Importance Effective therapies for patients with coronavirus disease 2019 (COVID-19) are
needed, and clinical trial data have demonstrated that low-dose dexamethasone reduced …

Interleukin-6 receptor antagonists in critically ill patients with Covid-19–preliminary report

Remap-Cap Investigators, AC Gordon, PR Mouncey… - Medrxiv, 2021 - medrxiv.org
Background The efficacy of interleukin-6 receptor antagonists in critically ill patients with
coronavirus disease 2019 (Covid-19) is unclear. Methods We evaluated tocilizumab and …

Effect of hydrocortisone on mortality and organ support in patients with severe COVID-19: the REMAP-CAP COVID-19 corticosteroid domain randomized clinical trial

…, S Berry, RJ Lewis, C McArthur, SA Webb, AC Gordon… - Jama, 2020 - jamanetwork.com
… Dr Gordon reported receiving grants from the NIHR and the NIHR Research Professorship;
nonfinancial support from the NIHR Clinical Research Network and the NIHR Imperial …

[HTML][HTML] Vasopressin versus norepinephrine infusion in patients with septic shock

…, KR Walley, J Singer, AC Gordon… - … England Journal of …, 2008 - Mass Medical Soc
Background Vasopressin is commonly used as an adjunct to catecholamines to support blood
pressure in refractory septic shock, but its effect on mortality is unknown. We hypothesized …

The artificial intelligence clinician learns optimal treatment strategies for sepsis in intensive care

M Komorowski, LA Celi, O Badawi, AC Gordon… - Nature medicine, 2018 - nature.com
Sepsis is the third leading cause of death worldwide and the main cause of mortality in
hospitals 1 , 2 – 3 , but the best treatment strategy remains uncertain. In particular, evidence …

Y90 radioembolization significantly prolongs time to progression compared with chemoembolization in patients with hepatocellular carcinoma

R Salem, AC Gordon, S Mouli, R Hickey, J Kallini… - Gastroenterology, 2016 - Elsevier
Background & Aims Conventional transarterial chemoembolization (cTACE) is used to treat
patients with hepatocellular carcinoma (HCC). Radioembolization is a minimally invasive …

[HTML][HTML] Genomic landscape of the individual host response and outcomes in sepsis: a prospective cohort study

…, P Hutton, TC Mills, A Rautanen, AC Gordon… - The Lancet …, 2016 - thelancet.com
Background Effective targeted therapy for sepsis requires an understanding of the
heterogeneity in the individual host response to infection. We investigated this heterogeneity by …